Receptor binding cancer antigen expressed on SiSo cells, a novel regulator of apoptosis of erythroid progenitor cells

Takamitsu Matsushima, Manabu Nakashima, Koichi Oshima, Yasunobu Abe, Junji Nishimura, Hajime Nawata, Takeshi Watanabe, Koichiro Muta

Research output: Contribution to journalArticle

89 Citations (Scopus)

Abstract

To better understand the control of apoptosis during erythropoiesis, this study investigated the role of a novel tumor-associated antigen, RCAS1 (receptor binding cancer antigen expressed on SiSo cells), with regard to the regulation of apoptosis of erythroid progenitor cells. Erythroid colony-forming cells (ECFCs) purified from human peripheral blood were used. Binding experiments of RCAS1 showed that ECFCs abundantly expressed receptors (RCAS1R) for RCAS1 and that the degree of binding of RCAS1 to the receptors diminished rapidly during erythroid maturation in vitro. When the soluble form of RCAS1 was added to the cultures, ECFCs underwent apoptosis, including collapse of the mitochondrial transmembrane potential, and activation of caspases 8 and 3. The addition of an anti-Fas blocking antibody or Fas-Fc failed to reduce the apoptosis induced by RCAS1, thereby indicating that effects of RCAS1 are independent of Fas activation. When binding of RCAS1 to normal bone marrow cells Was analyzed, RCAS1R was evident on cells with an immature erythroid phenotype (transferrin receptor+/glycophorin A-) but not with a mature phenotype (transferrin receptor-/glycophorin A+). Histochemical staining revealed the expression of RCAS1 in the cytoplasm of bone marrow macrophages. These findings indicate that RCAS1, which is mainly produced by macrophages in hematopoietic tissue, may have a crucial role in controlling erythropoiesis by modulating apoptosis of erythroid progenitor cells via a Fas-independent mechanism.

Original languageEnglish
Pages (from-to)313-321
Number of pages9
JournalBlood
Volume98
Issue number2
DOIs
Publication statusPublished - Jul 15 2001

Fingerprint

Erythroid Precursor Cells
Apoptosis
Antigens
Glycophorin
Transferrin Receptors
Macrophages
Erythropoiesis
Neoplasms
Bone
Chemical activation
Phenotype
Antigen Receptors
Blocking Antibodies
Caspase 8
Neoplasm Antigens
Caspase 3
Bone Marrow Cells
Membrane Potentials
Tumors
Cytoplasm

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Cite this

Matsushima, T., Nakashima, M., Oshima, K., Abe, Y., Nishimura, J., Nawata, H., ... Muta, K. (2001). Receptor binding cancer antigen expressed on SiSo cells, a novel regulator of apoptosis of erythroid progenitor cells. Blood, 98(2), 313-321. https://doi.org/10.1182/blood.V98.2.313

Receptor binding cancer antigen expressed on SiSo cells, a novel regulator of apoptosis of erythroid progenitor cells. / Matsushima, Takamitsu; Nakashima, Manabu; Oshima, Koichi; Abe, Yasunobu; Nishimura, Junji; Nawata, Hajime; Watanabe, Takeshi; Muta, Koichiro.

In: Blood, Vol. 98, No. 2, 15.07.2001, p. 313-321.

Research output: Contribution to journalArticle

Matsushima, T, Nakashima, M, Oshima, K, Abe, Y, Nishimura, J, Nawata, H, Watanabe, T & Muta, K 2001, 'Receptor binding cancer antigen expressed on SiSo cells, a novel regulator of apoptosis of erythroid progenitor cells', Blood, vol. 98, no. 2, pp. 313-321. https://doi.org/10.1182/blood.V98.2.313
Matsushima, Takamitsu ; Nakashima, Manabu ; Oshima, Koichi ; Abe, Yasunobu ; Nishimura, Junji ; Nawata, Hajime ; Watanabe, Takeshi ; Muta, Koichiro. / Receptor binding cancer antigen expressed on SiSo cells, a novel regulator of apoptosis of erythroid progenitor cells. In: Blood. 2001 ; Vol. 98, No. 2. pp. 313-321.
@article{4e9623df4fe546b5adc11e8168d67002,
title = "Receptor binding cancer antigen expressed on SiSo cells, a novel regulator of apoptosis of erythroid progenitor cells",
abstract = "To better understand the control of apoptosis during erythropoiesis, this study investigated the role of a novel tumor-associated antigen, RCAS1 (receptor binding cancer antigen expressed on SiSo cells), with regard to the regulation of apoptosis of erythroid progenitor cells. Erythroid colony-forming cells (ECFCs) purified from human peripheral blood were used. Binding experiments of RCAS1 showed that ECFCs abundantly expressed receptors (RCAS1R) for RCAS1 and that the degree of binding of RCAS1 to the receptors diminished rapidly during erythroid maturation in vitro. When the soluble form of RCAS1 was added to the cultures, ECFCs underwent apoptosis, including collapse of the mitochondrial transmembrane potential, and activation of caspases 8 and 3. The addition of an anti-Fas blocking antibody or Fas-Fc failed to reduce the apoptosis induced by RCAS1, thereby indicating that effects of RCAS1 are independent of Fas activation. When binding of RCAS1 to normal bone marrow cells Was analyzed, RCAS1R was evident on cells with an immature erythroid phenotype (transferrin receptor+/glycophorin A-) but not with a mature phenotype (transferrin receptor-/glycophorin A+). Histochemical staining revealed the expression of RCAS1 in the cytoplasm of bone marrow macrophages. These findings indicate that RCAS1, which is mainly produced by macrophages in hematopoietic tissue, may have a crucial role in controlling erythropoiesis by modulating apoptosis of erythroid progenitor cells via a Fas-independent mechanism.",
author = "Takamitsu Matsushima and Manabu Nakashima and Koichi Oshima and Yasunobu Abe and Junji Nishimura and Hajime Nawata and Takeshi Watanabe and Koichiro Muta",
year = "2001",
month = "7",
day = "15",
doi = "10.1182/blood.V98.2.313",
language = "English",
volume = "98",
pages = "313--321",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "2",

}

TY - JOUR

T1 - Receptor binding cancer antigen expressed on SiSo cells, a novel regulator of apoptosis of erythroid progenitor cells

AU - Matsushima, Takamitsu

AU - Nakashima, Manabu

AU - Oshima, Koichi

AU - Abe, Yasunobu

AU - Nishimura, Junji

AU - Nawata, Hajime

AU - Watanabe, Takeshi

AU - Muta, Koichiro

PY - 2001/7/15

Y1 - 2001/7/15

N2 - To better understand the control of apoptosis during erythropoiesis, this study investigated the role of a novel tumor-associated antigen, RCAS1 (receptor binding cancer antigen expressed on SiSo cells), with regard to the regulation of apoptosis of erythroid progenitor cells. Erythroid colony-forming cells (ECFCs) purified from human peripheral blood were used. Binding experiments of RCAS1 showed that ECFCs abundantly expressed receptors (RCAS1R) for RCAS1 and that the degree of binding of RCAS1 to the receptors diminished rapidly during erythroid maturation in vitro. When the soluble form of RCAS1 was added to the cultures, ECFCs underwent apoptosis, including collapse of the mitochondrial transmembrane potential, and activation of caspases 8 and 3. The addition of an anti-Fas blocking antibody or Fas-Fc failed to reduce the apoptosis induced by RCAS1, thereby indicating that effects of RCAS1 are independent of Fas activation. When binding of RCAS1 to normal bone marrow cells Was analyzed, RCAS1R was evident on cells with an immature erythroid phenotype (transferrin receptor+/glycophorin A-) but not with a mature phenotype (transferrin receptor-/glycophorin A+). Histochemical staining revealed the expression of RCAS1 in the cytoplasm of bone marrow macrophages. These findings indicate that RCAS1, which is mainly produced by macrophages in hematopoietic tissue, may have a crucial role in controlling erythropoiesis by modulating apoptosis of erythroid progenitor cells via a Fas-independent mechanism.

AB - To better understand the control of apoptosis during erythropoiesis, this study investigated the role of a novel tumor-associated antigen, RCAS1 (receptor binding cancer antigen expressed on SiSo cells), with regard to the regulation of apoptosis of erythroid progenitor cells. Erythroid colony-forming cells (ECFCs) purified from human peripheral blood were used. Binding experiments of RCAS1 showed that ECFCs abundantly expressed receptors (RCAS1R) for RCAS1 and that the degree of binding of RCAS1 to the receptors diminished rapidly during erythroid maturation in vitro. When the soluble form of RCAS1 was added to the cultures, ECFCs underwent apoptosis, including collapse of the mitochondrial transmembrane potential, and activation of caspases 8 and 3. The addition of an anti-Fas blocking antibody or Fas-Fc failed to reduce the apoptosis induced by RCAS1, thereby indicating that effects of RCAS1 are independent of Fas activation. When binding of RCAS1 to normal bone marrow cells Was analyzed, RCAS1R was evident on cells with an immature erythroid phenotype (transferrin receptor+/glycophorin A-) but not with a mature phenotype (transferrin receptor-/glycophorin A+). Histochemical staining revealed the expression of RCAS1 in the cytoplasm of bone marrow macrophages. These findings indicate that RCAS1, which is mainly produced by macrophages in hematopoietic tissue, may have a crucial role in controlling erythropoiesis by modulating apoptosis of erythroid progenitor cells via a Fas-independent mechanism.

UR - http://www.scopus.com/inward/record.url?scp=0035880241&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035880241&partnerID=8YFLogxK

U2 - 10.1182/blood.V98.2.313

DO - 10.1182/blood.V98.2.313

M3 - Article

VL - 98

SP - 313

EP - 321

JO - Blood

JF - Blood

SN - 0006-4971

IS - 2

ER -